Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...
AZ said adding YS2302018 to its pipeline strengthens its cardiovascular portfolio with a drug that could have potential in a ...
Rigel Pharma surged 50.1% due to strong revenue drivers, strategic partnerships, and undervaluation, justifying a Strong Buy ...
Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...
Hosted on MSN18h
India's pharma, meditech exports expected to sustain momentum despiteglobal slowdown: ReportExports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...
U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center in Indiana that will focus on ...
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Urogen Pharma (URGN – Research Report), with a ...
Jonathan Chang, an analyst from Leerink Partners, maintained the Buy rating on Vincerx Pharma Inc (VINC – Research Report). The ...
India's pharmaceutical and meditech exports are expected to continue strong growth despite global economic slowdown, driven ...
New York, USA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Executive appointments will drive growth strategy and progression of clinical pipeline Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback